Xatmep
Term · Oncology and biomedicine · MLC-T-ONC-009399
A drug used alone or with other drugs to treat many types of cancer, certain types of arthritis, and severe psoriasis (a type of skin condition). It is also being studied in the treatment of other conditions and types of cancer. Xatmep stops cells from using folic acid to make DNA and may kill cancer cells. It may also lower the body’s immune response. Xatmep is a type of antimetabolite and a type of antifolate. Also called methotrexate sodium, MTX, and Trexall.
| Identifier | MLC-T-ONC-009399 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | methotrexate sodium; MTX; Trexall |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009399",
"term": "Xatmep",
"field": "Oncology and biomedicine",
"definition": "A drug used alone or with other drugs to treat many types of cancer, certain types of arthritis, and severe psoriasis (a type of skin condition). It is also being studied in the treatment of other conditions and types of cancer. Xatmep stops cells from using folic acid to make DNA and may kill cancer cells. It may also lower the body’s immune response. Xatmep is a type of antimetabolite and a type of antifolate. Also called methotrexate sodium, MTX, and Trexall.",
"synonyms": [
"methotrexate sodium",
"MTX",
"Trexall"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/xatmep/"
}
Record 17,482 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.